
Artemide Lung 02 (NCT06692738)
Brief Summary
A Phase II clinical trial designed to investigate the effectiveness and safety of [intervention/drug name] in patients with advanced-stage lung cancer. The study focuses on progression-free survival and overall response rate.
Official Title
A Phase II Study Evaluating the Effectiveness of [Full Study Title Placeholder] in Patients with Advanced Lung Cancer.
Conditions
Advanced Non-Small Cell Lung Cancer (NSCLC)
Artemide Lung 03 (NCT06627647)
Brief Summary
This is a Phase I/II trial to evaluate the safety, tolerability, and early efficacy of [specific intervention] in patients with early-stage lung cancer. The study aims to determine the recommended dosage for further trials.
Official Title
A Phase I/II Trial Investigating [Full Study Title Placeholder] for Patients with Early-Stage Lung Cancer.
Conditions
Early-Stage Lung Cancer
